Charles River Laboratories International Inc ha un prezzo obiettivo di consenso di $213.65 basato sulle valutazioni di 21 analisti. Il massimo è $275, pubblicato da Wells Fargo il settembre 22, 2023. Il minimo è $160, pubblicato da JP Morgan il aprile 13, 2026. Le 3 valutazioni di analisti più recenti sono state pubblicate da CLSA, Mizuho e Morgan Stanley il luglio 20, 2026, luglio 13, 2026 e luglio 9, 2026. Con un prezzo obiettivo medio di $236.33 tra CLSA, Mizuho e Morgan Stanley, c’è una variazione implicita del 7.72% upside per Charles River Laboratories International Inc a partire da queste ultime valutazioni degli analisti.
1calcolato in base alle valutazioni degli analisti
L'ultimo obiettivo di prezzo per Charles River (NYSE:CRL) è stato riportato da CLSA in data luglio 20, 2026. La società di analisi ha fissato un obiettivo di prezzo per $219.00 prevedendo che CRL raggiunga fall entro 12 mesi (un possibile -0.18% downside).
L'ultima valutazione degli analisti per Charles River (NYSE:CRL) è stato fornita da CLSA e Charles River declassato il suo rating hold.
L'ultima revisione al rialzo di Charles River Laboratories International Inc è avvenuta il giugno 17, 2026, quando Morgan Stanley ha alzato il suo obiettivo di prezzo a $220. In precedenza Morgan Stanley aveva an equal-weight per Charles River Laboratories International Inc.
L'ultima revisione al ribasso di Charles River Laboratories International Inc si è verificata il luglio 20, 2026, quando CLSA ha modificato il suo obiettivo di prezzo da $219 a $219 per Charles River Laboratories International Inc.
Gli analisti giungono alle valutazioni dei titoli dopo aver fatto ricerche approfondite, che comprendono l'esame dei bilanci pubblici, i colloqui con i dirigenti e i clienti di Charles River e l'ascolto delle comunicazioni degli utili. La maggior parte degli analisti svolge questa attività ogni tre mesi, quindi dovresti ricevere 4 valutazioni all'anno per azienda e per società. L'ultima valutazione di Charles River è stata depositata il luglio 20, 2026, quindi dovresti aspettarti che la prossima valutazione sia disponibile intorno a luglio 20, 2027.
Sebbene le valutazioni siano soggettive e possano cambiare, l'ultima valutazione di Charles River (CRL) è stata una declassato con un obiettivo di prezzo di $219.00 a $219.00. Il prezzo attuale a cui Charles River (CRL) è scambiato è $219.40, che è out of del range previsto dall'analista.
Sfoglia valutazioni degli analisti e obiettivi di prezzo su tutte le azioni.
Dati e API: API Benzinga · API notizie azionarie · API valutazioni analisti · API logo aziende
Dati di mercato forniti da API Benzinga
| Buy Now | Get Alert | ||||||
|---|---|---|---|---|---|---|---|
| 07/20/2026 | Buy Now | -0.18% | CLSA | $219 → $219 | Downgrade | Outperform → Hold | Get Alert |
| 07/13/2026 | Buy Now | 4.83% | Mizuho | $192 → $230 | Maintains | Neutral | Get Alert |
| 07/09/2026 | Buy Now | 18.51% | Morgan Stanley | $220 → $260 | Maintains | Overweight | Get Alert |
| 06/17/2026 | Buy Now | 0.27% | Morgan Stanley | $185 → $220 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 05/29/2026 | Buy Now | -0.18% | CLSA | $167 → $219 | Upgrade | Hold → Outperform | Get Alert |
| 05/08/2026 | Buy Now | 0.27% | Barclays | $210 → $220 | Maintains | Overweight | Get Alert |
| 05/08/2026 | Buy Now | 0.27% | Evercore ISI Group | $200 → $220 | Maintains | Outperform | Get Alert |
| 04/14/2026 | Buy Now | -4.28% | Barclays | $200 → $210 | Maintains | Overweight | Get Alert |
| 04/13/2026 | Buy Now | -27.07% | JP Morgan | $165 → $160 | Maintains | Neutral | Get Alert |
| 02/25/2026 | Buy Now | -20.24% | UBS | $170 → $175 | Maintains | Neutral | Get Alert |
| 02/20/2026 | Buy Now | 7.11% | TD Cowen | $251 → $235 | Maintains | Buy | Get Alert |
| 02/20/2026 | Buy Now | -20.24% | Mizuho | $215 → $175 | Maintains | Neutral | Get Alert |
| 02/19/2026 | Buy Now | -8.84% | Barclays | $215 → $200 | Maintains | Overweight | Get Alert |
| 02/19/2026 | Buy Now | -8.84% | Evercore ISI Group | $260 → $200 | Maintains | Outperform | Get Alert |
| 01/16/2026 | Buy Now | 20.78% | Citigroup | $200 → $265 | Maintains | Buy | Get Alert |
| 01/13/2026 | Buy Now | 18.51% | Evercore ISI Group | $250 → $260 | Maintains | Outperform | Get Alert |
| 12/18/2025 | Buy Now | -8.84% | Mizuho | $174 → $200 | Maintains | Neutral | Get Alert |
| 12/15/2025 | Buy Now | -2.01% | Barclays | $210 → $215 | Maintains | Overweight | Get Alert |
| 12/15/2025 | Buy Now | -13.4% | JP Morgan | $165 → $190 | Maintains | Neutral | Get Alert |
| 11/11/2025 | Buy Now | -15.68% | Morgan Stanley | $170 → $185 | Maintains | Equal-Weight | Get Alert |
| 11/10/2025 | Buy Now | -10.21% | TD Cowen | $205 → $197 | Maintains | Buy | Get Alert |
| 11/06/2025 | Buy Now | -24.79% | JP Morgan | $160 → $165 | Maintains | Neutral | Get Alert |
| 11/06/2025 | Buy Now | -4.28% | Barclays | $195 → $210 | Maintains | Overweight | Get Alert |
| 11/06/2025 | Buy Now | -9.3% | Baird | $178 → $199 | Upgrade | Neutral → Outperform | Get Alert |
| 10/17/2025 | Buy Now | -20.69% | Mizuho | $155 → $174 | Maintains | Neutral | Get Alert |
| 10/06/2025 | Buy Now | — | William Blair | — | Upgrade | Market Perform → Outperform | Get Alert |
| 10/03/2025 | Buy Now | -8.84% | Evercore ISI Group | $190 → $200 | Maintains | Outperform | Get Alert |
| 10/02/2025 | Buy Now | -11.12% | Barclays | $165 → $195 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 09/09/2025 | Buy Now | -11.12% | Jefferies | $142 → $195 | Upgrade | Hold → Buy | Get Alert |
| 08/08/2025 | Buy Now | -13.4% | Evercore ISI Group | $180 → $190 | Maintains | Outperform | Get Alert |
| 08/07/2025 | Buy Now | -27.07% | JP Morgan | $145 → $160 | Maintains | Neutral | Get Alert |
| 08/07/2025 | Buy Now | -24.79% | Barclays | $155 → $165 | Maintains | Equal-Weight | Get Alert |
| 07/09/2025 | Buy Now | -17.96% | Evercore ISI Group | $170 → $180 | Maintains | Outperform | Get Alert |
| 07/09/2025 | Buy Now | -8.84% | Citigroup | $150 → $200 | Upgrade | Neutral → Buy | Get Alert |
| 05/23/2025 | Buy Now | -17.05% | Redburn Atlantic | $188 → $182 | Upgrade | Neutral → Buy | Get Alert |
| 05/08/2025 | Buy Now | -29.35% | Barclays | $145 → $155 | Maintains | Equal-Weight | Get Alert |
| 05/08/2025 | Buy Now | -36.19% | Baird | $118 → $140 | Maintains | Neutral | Get Alert |
| 04/10/2025 | Buy Now | -33.91% | Barclays | $160 → $145 | Maintains | Equal-Weight | Get Alert |
| 04/09/2025 | Buy Now | -29.35% | Mizuho | $175 → $155 | Maintains | Neutral | Get Alert |
| 03/21/2025 | Buy Now | -22.52% | Goldman Sachs | $190 → $170 | Downgrade | Buy → Neutral | Get Alert |
| 03/04/2025 | Buy Now | -20.24% | Citigroup | $155 → $175 | Upgrade | Sell → Neutral | Get Alert |
| 03/03/2025 | Buy Now | -14.31% | Redburn Atlantic | $171 → $188 | Upgrade | Sell → Neutral | Get Alert |
| 02/20/2025 | Buy Now | -24.79% | JP Morgan | $175 → $165 | Maintains | Neutral | Get Alert |
| 02/20/2025 | Buy Now | -21.15% | Baird | $177 → $173 | Maintains | Neutral | Get Alert |
| 02/20/2025 | Buy Now | -27.07% | Barclays | $166 → $160 | Maintains | Equal-Weight | Get Alert |
| 02/18/2025 | Buy Now | -24.34% | Barclays | $205 → $166 | Maintains | Equal-Weight | Get Alert |
| 02/05/2025 | Buy Now | -16.13% | Morgan Stanley | $220 → $184 | Maintains | Equal-Weight | Get Alert |
| 02/03/2025 | Buy Now | -20.24% | JP Morgan | $215 → $175 | Maintains | Neutral | Get Alert |
| 01/23/2025 | Buy Now | -13.4% | Goldman Sachs | $220 → $190 | Maintains | Buy | Get Alert |
| 01/22/2025 | Buy Now | — | William Blair | — | Downgrade | Outperform → Market Perform | Get Alert |
| 01/17/2025 | Buy Now | -15.68% | UBS | $250 → $185 | Downgrade | Buy → Neutral | Get Alert |
| 01/14/2025 | Buy Now | — | William Blair | — | Reiterates | Outperform → Outperform | Get Alert |
| 12/16/2024 | Buy Now | 0.27% | Morgan Stanley | $225 → $220 | Maintains | Equal-Weight | Get Alert |
| 12/13/2024 | Buy Now | -4.28% | B of A Securities | $220 → $210 | Maintains | Neutral | Get Alert |
| 11/11/2024 | Buy Now | 3.46% | TD Cowen | $203 → $227 | Maintains | Hold | Get Alert |
| 11/07/2024 | Buy Now | 13.95% | UBS | $240 → $250 | Maintains | Buy | Get Alert |
| 11/07/2024 | Buy Now | 2.55% | Evercore ISI Group | $190 → $225 | Maintains | In-Line | Get Alert |
| 10/23/2024 | Buy Now | -23.88% | CLSA | → $167 | Initiates | → Underperform | Get Alert |
| 10/16/2024 | Buy Now | -6.56% | Barclays | $210 → $205 | Maintains | Equal-Weight | Get Alert |
| 10/14/2024 | Buy Now | -31.18% | Redburn Atlantic | → $151 | Initiates | → Sell | Get Alert |
| 10/07/2024 | Buy Now | -13.4% | Evercore ISI Group | $225 → $190 | Downgrade | Outperform → In-Line | Get Alert |
| 10/02/2024 | Buy Now | -2.01% | B of A Securities | $250 → $215 | Downgrade | Buy → Neutral | Get Alert |
| 10/01/2024 | Buy Now | -20.24% | Citigroup | $215 → $175 | Downgrade | Neutral → Sell | Get Alert |
| 09/20/2024 | Buy Now | -13.4% | Baird | $191 → $190 | Maintains | Neutral | Get Alert |
| 08/12/2024 | Buy Now | -7.47% | TD Cowen | $228 → $203 | Maintains | Hold | Get Alert |
| 08/08/2024 | Buy Now | -2.01% | Morgan Stanley | $235 → $215 | Maintains | Equal-Weight | Get Alert |
| 08/08/2024 | Buy Now | -4.28% | Barclays | $230 → $210 | Maintains | Equal-Weight | Get Alert |
| 08/08/2024 | Buy Now | 9.39% | UBS | $290 → $240 | Maintains | Buy | Get Alert |
| 08/08/2024 | Buy Now | 2.55% | Evercore ISI Group | $265 → $225 | Maintains | Outperform | Get Alert |
| 08/08/2024 | Buy Now | 13.95% | Goldman Sachs | $290 → $250 | Maintains | Buy | Get Alert |
| 08/08/2024 | Buy Now | -6.56% | JP Morgan | $270 → $205 | Downgrade | Overweight → Neutral | Get Alert |
| 08/08/2024 | Buy Now | -12.94% | Baird | $239 → $191 | Downgrade | Outperform → Neutral | Get Alert |
| 07/10/2024 | Buy Now | 8.93% | Baird | $271 → $239 | Maintains | Outperform | Get Alert |
| 06/28/2024 | Buy Now | 4.83% | Barclays | → $230 | Initiates | → Equal-Weight | Get Alert |
| 06/28/2024 | Buy Now | — | Argus Research | — | Downgrade | Buy → Hold | Get Alert |
| 06/07/2024 | Buy Now | 7.11% | Mizuho | → $235 | Initiates | → Neutral | Get Alert |
| 06/06/2024 | Buy Now | 32.18% | Goldman Sachs | → $290 | Initiates | → Buy | Get Alert |
| 05/13/2024 | Buy Now | 3.92% | TD Cowen | $260 → $228 | Maintains | Hold | Get Alert |
| 05/10/2024 | Buy Now | 23.06% | Baird | $282 → $270 | Maintains | Outperform | Get Alert |
| 03/18/2024 | Buy Now | 32.18% | Argus Research | $240 → $290 | Maintains | Buy | Get Alert |
| 02/15/2024 | Buy Now | 27.62% | JP Morgan | $270 → $280 | Maintains | Overweight | Get Alert |
| 02/15/2024 | Buy Now | 20.78% | Evercore ISI Group | $260 → $265 | Maintains | Outperform | Get Alert |
| 02/15/2024 | Buy Now | 32.18% | UBS | $270 → $290 | Maintains | Buy | Get Alert |
| 02/15/2024 | Buy Now | 13.95% | Citigroup | $215 → $250 | Maintains | Neutral | Get Alert |
| 02/15/2024 | Buy Now | 22.15% | Baird | $252 → $268 | Maintains | Outperform | Get Alert |
| 02/15/2024 | Buy Now | — | Guggenheim | — | Downgrade | Buy → Neutral | Get Alert |
| 12/20/2023 | Buy Now | 23.06% | JP Morgan | $210 → $270 | Maintains | Overweight | Get Alert |
| 12/11/2023 | Buy Now | -2.01% | Citigroup | $190 → $215 | Maintains | Neutral | Get Alert |
| 11/10/2023 | Buy Now | -6.56% | Morgan Stanley | $220 → $205 | Maintains | Equal-Weight | Get Alert |
| 11/09/2023 | Buy Now | -2.01% | UBS | $250 → $215 | Maintains | Buy | Get Alert |
| 10/24/2023 | Buy Now | 0.27% | Morgan Stanley | $235 → $220 | Maintains | Equal-Weight | Get Alert |
| 09/25/2023 | Buy Now | -4.74% | TD Cowen | $212 → $209 | Maintains | Market Perform | Get Alert |
| 09/22/2023 | Buy Now | 16.68% | Baird | $267 → $256 | Maintains | Outperform | Get Alert |
| 09/22/2023 | Buy Now | 2.55% | Guggenheim | $255 → $225 | Maintains | Buy | Get Alert |
| 09/22/2023 | Buy Now | 25.34% | Wells Fargo | $280 → $275 | Maintains | Overweight | Get Alert |
| 09/13/2023 | Buy Now | -3.37% | TD Cowen | → $212 | Initiates | → Market Perform | Get Alert |
| 08/10/2023 | Buy Now | 13.95% | JP Morgan | $225 → $250 | Maintains | Overweight | Get Alert |
| 08/10/2023 | Buy Now | 11.67% | B of A Securities | $235 → $245 | Maintains | Buy | Get Alert |